Iambic Therapeutics, Inc.
IAM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001997038
In the last 90 days, Iambic Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of IAM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Iambic Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Qatar Investment Authority | 13G | 5.80%2.80M shares | New | Nov 9, 20261 filing | Nov 9, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Iambic Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 9, 202610:14 AM ET | Qatar Investment Authority | 13G | 5.80%2.80M shares | New | Oct 15, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Iambic Therapeutics, Inc. shares.
No Form 144 notices for Iambic Therapeutics, Inc. are on file.